Connect with us


Russia completes human trial of new COVID-19 vaccine



RUSSIA has completed the human trials of a new coronavirus vaccine with test patients used for the trials to be discharged soon.

According to Russian reports, the vaccine could be available by August.

  Russia sponsored and permitted clinical trials of two potential coronavirus vaccines. The first one was developed by the Gamaleya National Research Center for Epidemiology and Microbiology and carried out at the Burdenko Military Hospital, while the second one was given to test patients at the Sechenov First Moscow State Medical University.

  The report stated that 20 people volunteered for the trials and after they were injected, they were asked to quarantine in the hospital for 28 days.

  The tests performed on the volunteers in Russia was reported to have  shown that they were developing immunity to coronavirus, but the name of the drug wasn’t revealed.

  Elena Smolyarchuk, chief researcher for the Russian Center for Clinical Research on Medications at Sechenov University, said “the research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20.

  Russia has reported 719,449 cases of Coronavirus, with 11,188 people dying from complications caused by the disease.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *